Front. Med. Frontiers in Medicine Front. Med. 2296-858X Frontiers Media S.A. 10.3389/fmed.2023.1251795 Medicine Correction Corrigendum: The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome Xiao Qiufeng 1 2 3 4 † Wu Xunyao 5 † Deng Chuiwen 1 2 3 4 Zhao Lidan 1 2 3 4 Peng Linyi 1 2 3 4 Zhou Jiaxin 1 2 3 4 * Zhang Wen 1 2 3 4 Zhao Yan 1 2 3 4 Fei Yunyun 1 2 3 4 * 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases, Ministry of Science and Technology, Beijing, China 3State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 4Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China 5Clinical Biobank, Department of Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Jiaxin Zhou pumczhou@sina.com Yunyun Fei feiyunyun@pumch.cn

†These authors have contributed equally to this work

 11 07 2023 2023 10 1251795 02 07 2023 03 07 2023 Copyright © 2023 Xiao, Wu, Deng, Zhao, Peng, Zhou, Zhang, Zhao and Fei. 2023 Xiao, Wu, Deng, Zhao, Peng, Zhou, Zhang, Zhao and Fei

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A corrigendum on The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome by Xiao, Q., Wu, X., Deng, C., Zhao, L., Peng, L., Zhou, J., Zhang, W., Zhao, Y., and Fei, Y. (2022). Front. Med. 9:959388. doi: 10.3389/fmed.2022.959388 primary Sjögren's syndrome N6-methyladenosine METTL3 ALKBH5 YTHDF readers ISG15 section-at-acceptance Translational Medicine

In the published article, there was an error in affiliation 1. Instead of “Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China”, it should be “Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.